These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2402247)

  • 1. Calcium is essential for both the membrane binding and lytic activity of pore-forming protein (perforin) from cytotoxic T-lymphocyte.
    Ishiura S; Matsuda K; Koizumi H; Tsukahara T; Arahata K; Sugita H
    Mol Immunol; 1990 Aug; 27(8):803-7. PubMed ID: 2402247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of membrane binding and lytic activities of the lymphocyte pore-forming protein (perforin).
    Young JD; Damiano A; DiNome MA; Leong LG; Cohn ZA
    J Exp Med; 1987 May; 165(5):1371-82. PubMed ID: 3494808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a Ca-dependent erythrolytic protein (perforin) from cytotoxic T-lymphocytes.
    Ishiura S; Anraku H; Kamo I; Koizumi H; Arahata K; Sugita H
    J Biochem; 1987 Jul; 102(1):9-12. PubMed ID: 3499435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the inhibitory effect of lysolipids on perforin-mediated hemolysis.
    Ojcius DM; Young JD
    Mol Immunol; 1990 Mar; 27(3):257-61. PubMed ID: 2342489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A calcium- and perforin-independent pathway of killing mediated by murine cytolytic lymphocytes.
    Young JD; Clark WR; Liu CC; Cohn ZA
    J Exp Med; 1987 Dec; 166(6):1894-9. PubMed ID: 3500267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of CTL to perforin-mediated lysis. Evidence for a lymphocyte membrane protein interacting with perforin.
    Müller C; Tschopp J
    J Immunol; 1994 Sep; 153(6):2470-8. PubMed ID: 7521362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S; Persechini PM; Perussia B; Young JD
    J Immunol; 1989 Sep; 143(5):1453-60. PubMed ID: 2503557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules.
    Podack ER; Young JD; Cohn ZA
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8629-33. PubMed ID: 2417226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects.
    Berke G
    Annu Rev Immunol; 1994; 12():735-73. PubMed ID: 8011296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane-associated proteins with the ability to partially inhibit perforin-mediated lysis.
    Ojcius DM; Muller S; Hasselkus-Light CS; Young JD; Jiang S
    Immunol Lett; 1991 May; 28(2):101-8. PubMed ID: 1885208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to the pore-forming protein of cytotoxic T cells: comparison of target cell membrane rigidity.
    Ojcius DM; Jiang SB; Persechini PM; Storch J; Young JD
    Mol Immunol; 1990 Sep; 27(9):839-45. PubMed ID: 2215476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane channel formation by the lymphocyte pore-forming protein: comparison between susceptible and resistant target cells.
    Persechini PM; Young JD; Almers W
    J Cell Biol; 1990 Jun; 110(6):2109-16. PubMed ID: 1693622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of heparin and other acid mucopolysaccharides on the activity of a cytolytic pore-forming protein (perforin) from cytotoxic T-lymphocytes.
    Ishiura S; Koizumi H; Tsukahara T; Sugita H
    J Biochem; 1988 Jan; 103(1):11-3. PubMed ID: 2966147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target cell lysis by cytotoxic T lymphocytes that lack detectable hemolytic perforin activity.
    Allbritton NL; Nagler-Anderson C; Elliott TJ; Verret CR; Eisen HN
    J Immunol; 1988 Nov; 141(10):3243-8. PubMed ID: 3263417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility of type III erythrocytes of paroxysmal nocturnal hemoglobinuria to lysis mediated by complement and perforin.
    Jiang S; Persechini PM; Rosse WF; Perussia B; Young JD
    Biochem Biophys Res Commun; 1989 Jul; 162(1):316-25. PubMed ID: 2751655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities.
    Young JD; Cohn ZA; Podack ER
    Science; 1986 Jul; 233(4760):184-90. PubMed ID: 2425429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylcholine acts as a Ca2+-dependent receptor molecule for lymphocyte perforin.
    Tschopp J; Schäfer S; Masson D; Peitsch MC; Heusser C
    Nature; 1989 Jan; 337(6204):272-4. PubMed ID: 2783478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
    Lancki DW; Hsieh CS; Fitch FW
    J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasts from cytotoxic T lymphocytes are resistant to perforin-mediated lysis.
    Ojcius DM; Jiang SB; Persechini PM; Detmers PA; Young JD
    Mol Immunol; 1991 Sep; 28(9):1011-8. PubMed ID: 1922107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the lytic activity of perforin (cytolysin) and of late complement components by proteoglycans.
    Tschopp J; Masson D
    Mol Immunol; 1987 Sep; 24(9):907-13. PubMed ID: 3498887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.